Bioengine
Founded Year
2014Stage
Series B - III | AliveTotal Raised
$31.39MLast Raised
$31.39M | 10 mos agoAbout Bioengine
Bioengine focuses on providing serum-free medium products and technical services for the biopharmaceutical industry such as antibodies, vaccines, and cell gene therapy.
Missing: Bioengine's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Bioengine's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Bioengine Frequently Asked Questions (FAQ)
When was Bioengine founded?
Bioengine was founded in 2014.
Where is Bioengine's headquarters?
Bioengine's headquarters is located at 5th Floor, Building 1, Cailun Road 720 Nong, Shanghai.
What is Bioengine's latest funding round?
Bioengine's latest funding round is Series B - III.
How much did Bioengine raise?
Bioengine raised a total of $31.39M.
Who are the investors of Bioengine?
Investors of Bioengine include Hankang Equity Investment Management, Qingsong Capital, Legend Capital, Addor Capital, Wensong Tan and 7 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.